Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome

NCT05397405 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Intracranial Artery Stenosis

Interventions

DRUG: PCSK9 inhibitor

Sponsor

Nanjing First Hospital, Nanjing Medical University